The importance of anaplastic lymphoma kinase (ALK) as an oncogene in non-small cell lung cancer (NSCLC) has emerged as a major concern due to a dramatic clinical effect of targeted therapy. As compared with the research for targeted therapy, the study about clinicopathological characteristics for ALK positive NSCLC hasn't been worked enough. Here, we describe a 35-year-old woman diagnosed with stage IVb NSCLC with ALK rearrangement. During evaluating her disease, a metastatic lesion to uterine cervix was found. Although lung cancer metastasis to female genital tract is rare, we also present case series that show a metastasis to the female genital tract in NSCLC with ALK rearrangement. These case series could suggest that ALK positive NSCLC has distinct metastatic pattern.
INTRODUCTION
Metastatic lung cancer to the female genital tract is too rare.
There are a few reported cases of metastasis to the female genital tract-endometrium, cervix, vagina, and ovary. Clinicians have trouble to differentiate metastatic carcinoma from gynecological origin tumor. We report a case of lung adenocarcinoma with metastasis to the uterine cervix. This is the first case of uterine cervix metastasis of anaplastic lymphoma kinase (ALK) rearranged lung adenocarcinoma. Recently, three cases of ovarian metastasis from ALK rearranged non-small cell lung cancer (NSCLC) have been reported [1] [2] [3] . These reports could suggest ALK rearranged lung cancer would have distinct mechanism of metastasis.
CASE REPORT
A 35-year-old woman, non-smoker, was referred to the emergency department complaining dyspnea. In the previous hospital, seven days before, computed tomography (CT) on chest showed circumscribed mass with internal cavity and pericardial effusion. Pathologic result was chronic cervicitis. Because lung metastasis to the cervix was rare, immunohistochemistry was performed on cervix smear using thyroid transcription factor-1 (TTF-1). The cervical smear was strong positive for TTF-1 (Fig. 1B) . She was finally diagnosed cervical metastasis from lung adenocarcinoma with ALK rearrangement. She was initially treated with crizotinib with partial response after 2 month. After 5 month, follow-up CT scan on chest showed progressed disease in lung cancer. Now she has treated for pemetrexed, cisplatin, and crizotinib.
DISCUSSION
Lung cancer metastasis to the female genital tract is too rare.
Only some cases have been reported including involvement of ovary, endometrium, vagina, and cervix. We identified eleven patients with metastatic activity to the female genital tract (Table 1) [ [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Because of a lack of clinical information, we excluded earlier reported 32 cases of ovarian metastasis by Irving and Young [15] . Six patients of them were metastasis to ovarian, two of them to cervix, two patients to vagina, and one patient were to endometrium. Seven patients had metastatic disease at diagnosis. Six patients of them had complained of vaginal bleeding and other three patients had complained of urinary frequency or abdominal pain.
The others were detected the suspicious lesion for screening testpap smear or CT scan. All metastatic lesions were confirmed by biopsy. Especially, nine patients were adenocarcinoma with positive for TTF-1. In our case, a patient didn't complain for gynecologic symptom, so elevated CA-125 level was a clue to be suspicious of gynecologic malignancy. A pap smear showed adenocarcinoma, and positive for TTF-1.
ALK rearrangements define a distinct molecular subtype of lung cancer. ALK positive NSCLC tends to be present with no smoking habit, younger age, and adenocarcinoma. Fan et al. [16] reported ALK rearrangements tended to be present in NSCLC patients with tumor stage IV. Doebele et al. [17] reported that ALK gene rearrangement was significantly associated with pericardial disease. Recently three cases which are lung adenocarcinoma with ALK rearranged showing ovarian metastasis were reported [1] [2] [3] ( Table 2) . A patient of case 1 was suspected metastasis as PET-CT showed high uptake in ovaries at first diagnosed time, and patients of case 2 and 3 were suspected recurrence after chemotherapy. All three patients have been done oophorectomy to differentiate double primary cancer, biopsy confirmed metastatic lung adenocarcinoma. Less common sites of metastatic spread were also reported in ALK positive patients including gastric cardia or orbital area [18, 19] . These cases suggest ALK rearranged lung carcinoma has a distinct metastatic behavior.
Testing for ALK translocation-FISH in lung cancer was commercialized for only 5 years ago, so study for ALK negative versus ALK positive lung adenocarcinoma wasn't reported enough. We suppose that many patients of lung cancer metastasis to the genital tract wouldn't been caught. In the reported cases, clinicians ini- tially suspected a primary gynecological tumor, and examined the gynecologic study.
In conclusion, we report an ALK gene rearranged metastatic lung adenocarcinoma to uterine cervix. Recent reports which are ALK positive lung adenocarcinoma with less site of metastatic spread suggest ALK positive lung adenocarcinoma has different metastatic mechanism. Surely, further study for metastatic mechanism of ALK positive lung cancer and additional case report is necessary. To detect metastatic lesion, we recommend a pap smear and a biopsy of any suspicious lesion.
